PISCIANZ, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 5.935
EU - Europa 3.979
AS - Asia 2.256
SA - Sud America 253
AF - Africa 69
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.508
Nazione #
US - Stati Uniti d'America 5.845
PL - Polonia 2.106
SG - Singapore 797
CN - Cina 504
IT - Italia 473
SE - Svezia 368
VN - Vietnam 261
HK - Hong Kong 247
BR - Brasile 185
UA - Ucraina 164
FR - Francia 160
DE - Germania 152
BD - Bangladesh 101
GB - Regno Unito 99
FI - Finlandia 83
RU - Federazione Russa 83
TR - Turchia 83
KR - Corea 69
IE - Irlanda 68
NL - Olanda 63
BG - Bulgaria 57
IN - India 54
CA - Canada 37
MX - Messico 27
AR - Argentina 26
BE - Belgio 21
JP - Giappone 21
ES - Italia 19
SN - Senegal 18
MA - Marocco 15
AT - Austria 14
VE - Venezuela 11
ZA - Sudafrica 11
IQ - Iraq 10
PK - Pakistan 10
SA - Arabia Saudita 10
AU - Australia 9
PH - Filippine 9
DK - Danimarca 8
ID - Indonesia 8
IL - Israele 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
TH - Thailandia 7
CL - Cile 6
EC - Ecuador 6
MY - Malesia 6
CH - Svizzera 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
EG - Egitto 5
IR - Iran 5
JO - Giordania 5
LT - Lituania 5
PT - Portogallo 5
RO - Romania 5
EU - Europa 4
HN - Honduras 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
DZ - Algeria 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
EE - Estonia 1
FJ - Figi 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 12.501
Città #
Warsaw 2.055
Ashburn 593
Fairfield 587
Woodbridge 534
Singapore 488
Houston 439
Chandler 323
Ann Arbor 309
San Jose 270
Seattle 266
Wilmington 259
Hong Kong 241
Jacksonville 167
Cambridge 160
Beijing 129
Chicago 124
Los Angeles 123
Trieste 115
Princeton 94
Boardman 92
Ho Chi Minh City 71
Columbus 64
Seoul 61
Izmir 57
Sofia 57
Dallas 55
Dublin 54
Dearborn 51
Hanoi 49
Santa Clara 47
New York 46
Lauterbourg 45
Council Bluffs 42
Zgierz 41
Frankfurt am Main 39
Moscow 38
Salt Lake City 38
Buffalo 36
Dong Ket 36
Hefei 32
Milan 32
Munich 30
Rome 29
San Diego 27
The Dalles 27
Helsinki 25
Düsseldorf 23
Elk Grove Village 23
London 21
Orem 21
São Paulo 21
Tampa 21
Brussels 19
Phoenix 19
Dakar 18
Jinan 18
Nanjing 16
Brooklyn 14
Da Nang 14
Des Moines 13
Falls Church 13
Montreal 13
Shannon 13
Casablanca 12
Guangzhou 12
Haiphong 12
Kunming 12
Stockholm 12
Tokyo 12
Atlanta 11
Denver 11
Portsmouth 11
Shanghai 11
Chennai 10
Mumbai 10
Nuremberg 10
Poplar 10
Redondo Beach 10
Redwood City 10
Turku 10
Amsterdam 9
Bremen 9
Kocaeli 9
San Francisco 9
Washington 9
Catania 8
Hebei 8
Johannesburg 8
Manchester 8
Mexico City 8
Ottawa 8
Sydney 8
Tianjin 8
Vienna 8
Bexley 7
Boston 7
Grafing 7
Hangzhou 7
Lancaster 7
Sterling 7
Totale 9.142
Nome #
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 630
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 486
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 455
Neuronal Dysfunction Associated with Cholesterol Deregulation. 437
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 415
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 415
Type i interferon-mediated autoinflammation due to DNase II deficiency 411
Altered pattern of tumor necrosis factor-Alpha production in peripheral blood monocytes from Crohn's disease basic study 398
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 394
Knockdown of MVK does not lead to changes in NALP3 expression or activation 371
Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs 356
Clinical Genetic Testing of Periodic Fever Syndromes 312
An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers 307
Impact of methylmercury and other heavy metals exposure on neurocognitive function in children of 7 years old: study protocol of the follow-up 304
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 295
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 289
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 286
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 283
Piccolipiù, a multicenter birth cohort in Italy: protocol of the study. 278
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 276
In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords 275
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 265
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 263
The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation 250
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 246
Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. 239
Regulatory T-Cell Function Is Impaired in Celiac Disease. 235
Putative modifier genes in mevalonate kinase deficiency 216
Selective resistance to different glucocorticoids in severe autoimmune disorders 207
From Bone Marrow Transplantation to Cellular Therapies: Possible Therapeutic Strategies in Managing Autoimmune Disorders 195
Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies 193
Corrigendum to “Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency” [Immunol. Lett. 214 (2019) 52–54](S0165247819302342)(10.1016/j.imlet.2019.08.003) 190
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 189
Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic 187
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 181
Pulmonary arterial hypertension in interferonophaties: a case report and a review of the literature 181
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 174
Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies 166
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 164
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 163
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 162
Hydroxychloroquine modulates immunological pathways activated by RNA:DNA hybrids in Aicardi–Goutières syndrome patients carrying RNASEH2 mutations 161
New Mechanisms in Autoinflammatory Diseases 151
Priming of the cgas‐sting‐tbk1 pathway enhances lps‐induced release of type i interferons 150
Familial hypogammaglobulinemia with high RTE and naïve T lymphocytes 131
The effect of clodronate on a mevalonate kinase deficiency cellular model. 124
Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency 111
null 109
null 108
Totale 12.784
Categoria #
all - tutte 31.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022714 37 30 71 60 48 54 35 27 79 64 43 166
2022/20231.001 114 158 71 133 89 141 6 95 123 16 39 16
2023/2024596 24 46 47 29 55 59 122 106 5 9 43 51
2024/20251.307 22 51 106 136 124 90 96 86 172 171 130 123
2025/20263.321 617 105 198 197 273 240 508 98 376 392 166 151
2026/202765 65 0 0 0 0 0 0 0 0 0 0 0
Totale 12.784